Table 1. The associations of Hsp60 expression with clinical characteristics of HCC patients.

Variables	No. of cases	Hsp60 expression		P value (χ2 test)
		Low	High
Total	295	120	175
Age (years)				0.620
<54	160	63	97
≥54	135	57	78
Gender				0.394
female	36	17	19
male	259	103	156
HBsAg				0.298
Negative	23	7	16
Positive	272	113	159
AFP(ng/ml)				0.020
<200	169	59	110
≥200	126	61	65
Tumor size(cm)				0.741
<5	122	51	71
≥5	173	69	104
Tumor number				0.596
Single	234	97	137
Multiple	61	23	38
Differentiation grade				0.004
I+II	78	21	57
III+IV	217	99	118
TNM stage				0.680
I+II	230	95	135
III+IV	65	25	40
PVTT				0.361
No	262	105	157
Yes	33	15	18
Adjuvant TACE therapy				0.855
No	218	88	130
Yes	77	32	45
Death				0.742
No	186	77	109
Yes	109	43	66
Relapse				0.450
No	108	47	61
Yes	287	73	114

AFP, alpha-fetoprotein; HBsAg, hepatitis B virus surface antigen; HCC, hepatocellular carcinoma; Hsp60, heat shock protein 60; PVTT, portal vein tumor thrombus; TACE, transcatheter arterial chemoembolization.